Cipla Investor Relations Material
Latest events
Q3 24/25
Cipla
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cipla Limited
Access all reports
Cipla Limited develops, manufactures, and markets pharmaceuticals products in India, the United States, South Africa, and internationally. It offers active pharmaceutical ingredients (APIs) and intermediates that comprise anesthetics/sedatives; analytical reference standards; antiretrovirals/antiretroviral intermediates; anticancer/oncology related APIs and intermediates; cardiovascular; dermatological, hair fall control drugs; diabetology; erectile dysfunction drugs; gastroenterology; malaria treatment drugs; musculoskeletal disorders related APIs and intermediates; nephrology-urology-anti-urolithiatic products; nepirology-urology-anti-urolithiatic products; nutritional supplements/vitamins/minerals/trace elements and herbal extracts for human health care products, as well as APIs for cosmetics industries. The company was incorporated in 1935 and is headquartered in Mumbai, India.
Key slides for Cipla Limited
Q3 24/25
Cipla Limited
Q4 23/24
Cipla Limited
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CIPLA
Country
🇮🇳 India